The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site-Reference-Cited by-同舟云学术

The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site

Published:2011-02-17 Issue:3 Volume:12 Page:213-221
ISSN:1466-4879
Container-title:Genes & Immunity
language:en
Short-container-title:Genes Immun

Author:

Stickler M M,Reddy A,Xiong J M,Hinton P R,DuBridge R,Harding F A

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Immunology

Link

http://www.nature.com/articles/gene201068.pdf

Reference49 articles.

1. Lefranc M-P, Lefranc G . The Immunoglobulin FactsBook. Academic Press: San Diego, 2001.

2. Schroeder Jr HW, Hillson JL, Perlmutter RM . Early restriction of the human antibody repertoire. Science 1987; 238: 791–793.

3. Faure M, Sanchez P, Cazenave PA, Rueff-Juy D . T cell tolerance to kappa light chain (L kappa): identification of a naturally processed self-C kappa-peptidic region by specific CD4+ T cell hybridomas obtained in L kappa-deficient mice. Cell Immunol 1997; 180: 84–92.

4. Lieberman R, Humphrey Jr W . Association of H-2 types with genetic control of immune reponsiveness to IgG (gamma2a) allotypes in the mouse. J Exp Med 1972; 136: 1222–1230.

5. Bruggemann M, Winter G, Waldmann H, Neuberger MS . The immunogenicity of chimeric antibodies. J Exp Med 1989; 170: 2153–2157.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Constant domain polymorphisms influence monoclonal antibody stability and dynamics;Protein Science;2023-02-24

2. IGHG1 induces EMT in gastric cancer cells by regulating TGF-β/SMAD3 signaling pathway;Journal of Cancer;2021

3. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation;Frontiers in Immunology;2020-08-21

4. The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies;Frontiers in Immunology;2020-08-18

5. Design, creation and in vitro testing of a reduced immunogenicity humanized anti-CD25 monoclonal antibody that retains functional activity;Protein Engineering, Design and Selection;2019-12